Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication Monitor (RMM) that provides continuous, real-time data on methadone levels in interstitial fluid (ISF). An RMM could be used as a medication adherence monitor and would allow for the physician, counselor, patient, or family member to remotely verify that a physician-prescribed dose has been taken.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
LC-MS based Proteome analysis of dermal interstitial fluid in non opioid use disordered patients
Timeframe: 1 day
Methadone Concentration in ISF before and after a dose
Timeframe: 1 day
Methadone Concentration in blood before and after a dose
Timeframe: 1 day
Concentration of Methadone in ISF with LC-MS versus Electrochemical Assay
Timeframe: 2 days
Concentration of Methadone in blood with LC-MS versus Electrochemical Assay
Timeframe: 2 days
Pearson Correlation of Methadone between ISF and Blood
Timeframe: 2 days
Pearson Correlation between DPV and LC-MS ISF Methadone
Timeframe: 2 days
Pearson Correlation between DPV and LC-MS ISF EDDP
Timeframe: 2 days
Pearson Correlation between DPV and LC-MS blood EDDP
Timeframe: 2 days
EDDP concentration in ISF before and after daily dose of methadone
Timeframe: 1 day
EDDP concentration in blood before and after daily dose of methadone
Timeframe: 1 day
EMDP concentration in ISF before and after daily dose of methadone
Timeframe: 1 day
EMDP concentration in blood before and after daily dose of methadone
Timeframe: 1 day
Pearson Correlation of Methadone to Metabolite Ratio ( MMR ) between ISF and Blood using LC-MS
Timeframe: 2 days
Pearson Correlation of Methadone to Metabolite Ratio ( MMR ) between ISF and Blood using DPV
Timeframe: 2 days